PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-772

Market Sentiment is a fickle mistress ,,, Trust has to be earned and confidence is always extremely difficult to regain..

If PAA thought it was difficult gaining market awareness previously then building Trust and Confidence now whilst trying to deliver market awareness compounds the difficulty... anyone completing any DD is faced with a recent BOD change out...The New BOD have a significant task ahead.

I'm confident the New BOD understand the tasks at hand ,,,, BUT they require awareness and need to deliver... this round of funding certainly isn't Non Dilutive.. and they will need to spin how the rest of the funds are to be raised to enable SH a modicum of confidence...

SH receiving phone calls is industry standard but I do sense the current SH base is financially drained from recent CR and Options etc etc .

Short timeline ahead with only a Phase II required to garnish Big Pharma Interest... all going well 2nd quarter of 2025 will have the 24 week interim data . NZT